Top-Performing Pharmaceutical Companies Update Standard Response Documents Annually

RESEARCH TRIANGLE PARK, N.C. - (BUSINESS WIRE) - To accurately respond to incoming inquiries, medical information teams must regularly review their standard response documents. These teams must keep tabs on their companies' ongoing clinical trials, as well as third-party trials that feature their products, to keep up with physicians' questions.

Cutting Edge Information's study, "Medical Information Teams and Call Center Management" found that the majority of medical information teams review and update their standard response documents annually. Forty-five percent of Top 20 pharmaceutical companies review their response letters yearly, as do 75% of Top 50 companies and 58% of small and biotech companies.

Of course, a significant amount of surveyed medical information teams review their standard response documents at other frequencies. Surveyed companies also reported quarterly document reviews at 18% of Top 20 companies, 25% of Top 50 companies and 17% of small and biotech companies. Top 20 and small and biotech companies also reportedly conduct monthly reviews at 18% and 17% of surveyed companies, respectively. Top 20 pharmaceutical companies are the only ones to conduct weekly reviews (18%).